FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to neurology, and can be used for diagnosing vegetative disorders accompanying post-COVID syndrome in school-aged children using laboratory data. Patient’s saliva is analysed for quantitative content of monocyte chemotactic protein-1 by solid-phase ELISA. If its value is from 3.5 to 19.64 pg/ml, the absence of vegetative disturbances is stated in post-COVID syndrome. If the value of monocytic chemotactic protein-1 is 19.65 pg/ml and more, vegetative disorders are diagnosed in post-COVID syndrome.
EFFECT: method provides the possibility of increasing the specificity and accuracy, accessibility, non-invasiveness, objectifying the diagnosis of vegetative disorders in school-aged children by determining the content of monocytic chemotactic protein-1 in the patient's saliva.
1 cl, 3 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD OF PREDICTING THE FORMATION OF POST-COVID SYNDROME IN THE GASTROINTESTINAL TRACT BASED ON THE DETERMINATION OF IMMUNOLOGICAL MARKERS | 2023 | 
 | RU2807947C1 | 
| METHOD FOR OBJECTIVE ASSESSMENT OF VEGETATIVE DISORDERS IN ADOLESCENTS SUFFERING COVID-19 | 2024 | 
 | RU2821560C1 | 
| METHOD OF PREDICTING THE DEVELOPMENT OF PULMONARY EMBOLISM DURING THE PREVENTION OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH A NEW CORONAVIRUS INFECTION | 2023 | 
 | RU2802386C1 | 
| METHOD OF ASSESSING THE RISK OF DEATH IN PATIENTS WITH A NEW CORONAVIRUS INFECTION | 2023 | 
 | RU2802422C1 | 
| METHOD FOR EARLY DETECTION OF NEUROLOGICAL DISORDERS IN PATIENTS WITH COVID-19 | 2021 | 
 | RU2779562C1 | 
| BIOMARKER AND METHODS FOR EARLY DIAGNOSIS OF ALZHEIMER'S DISEASE | 2015 | 
 | RU2687272C2 | 
| METHOD FOR PREDICTING PROGRESSION OF VASCULAR MODERATE COGNITIVE IMPAIRMENT | 2023 | 
 | RU2816620C1 | 
| DIAGNOSTIC METHOD OF SEVERITY DEGREE OF DIABETIC ENCEPHALOPATHY WITH CHILDREN AND TEENAGERS | 2008 | 
 | RU2368905C1 | 
| METHOD OF TREATING POST-COVID ASTHENIC SYNDROME | 2024 | 
 | RU2834765C1 | 
| METHOD FOR PREDICTION OF EXCESSIVE ARTERIAL STIFFNESS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 MONTHS AFTER SUFFERING COVID-19 | 2024 | 
 | RU2833775C1 | 
Authors
Dates
2024-03-11—Published
2023-11-30—Filed